151 related articles for article (PubMed ID: 9568085)
1. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.
Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1998; 18(1A):247-52. PubMed ID: 9568085
[TBL] [Abstract][Full Text] [Related]
2. [Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].
Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
Gan To Kagaku Ryoho; 1998 Jan; 25(1):79-87. PubMed ID: 9464333
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.
Uchida N; Takeda Y; Kasai H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1998; 18(5A):3375-9. PubMed ID: 9858911
[TBL] [Abstract][Full Text] [Related]
4. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
Uchida N; Takeda Y; Kasai H; Hojo K; Wada T; Nishida K; Maekawa R; Sugita K; Yoshioka T
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2267-74. PubMed ID: 9881084
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
Uchida N; Yamada H; Maekawa R; Yoshioka T
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1943-9. PubMed ID: 12465394
[TBL] [Abstract][Full Text] [Related]
7. Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.
Uchida N; Takeda Y; Hojo K; Maekawa R; Sugita K; Yoshioka T
Eur J Cancer; 1998 Oct; 34(11):1796-801. PubMed ID: 9893671
[TBL] [Abstract][Full Text] [Related]
8. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
Fujita F; Fujita M; Sakamoto Y; Taguchi T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):215-21. PubMed ID: 8382036
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of combined nedaplatin and docetaxel therapy for human head and neck cancer in vivo.
Yamada H; Maki H; Takeda Y; Orita S
Anticancer Res; 2006; 26(2A):989-94. PubMed ID: 16619497
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity by long-term administration of low-dose etoposide].
Kusama K; Ekimoto H; Ishii T; Okamoto K; Takahashi K
Gan To Kagaku Ryoho; 1991 May; 18(6):959-63. PubMed ID: 2029199
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation study of nedaplatin with 5-fluorouracil in combination with alternating radiotherapy in patients with head and neck cancer.
Fuwa N; Kodaira T; Tachibana H; Nakamura T; Daimon T
Jpn J Clin Oncol; 2007 Mar; 37(3):161-7. PubMed ID: 17332057
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
14. Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel.
Yamada H; Uchida N; Maekawa R; Yoshioka T
Cancer Lett; 2001 Oct; 172(1):17-25. PubMed ID: 11595125
[TBL] [Abstract][Full Text] [Related]
15. [Combination of etoposide with cisplatin or cyclophosphamide in the treatment of mouse Lewis lung carcinoma].
Uchida T; Okamoto K; Nishikawa K; Takahashi K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):75-9. PubMed ID: 3753643
[TBL] [Abstract][Full Text] [Related]
16. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
Suzumura Y; Kato T; Ueda R; Ota K
Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
[TBL] [Abstract][Full Text] [Related]
18. Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer.
Matsumoto M; Takeda Y; Maki H; Hojo K; Wada T; Nishitani Y; Maekawa R; Yoshioka T
Jpn J Cancer Res; 2001 Jan; 92(1):51-8. PubMed ID: 11173544
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.
Uchida N; Yoshida H; Yamada H; Wada T; Daikatsu K; Ikeuchi I; Maekawa R; Sugita K; Yoshioka T
Jpn J Cancer Res; 1999 Aug; 90(8):887-94. PubMed ID: 10543262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]